bioLytical Laboratories

Works in GI & liver · Immunology · Infectious disease · Renal & urogenital · Respiratory

bioLytical Laboratories is a clinical trial sponsor. It has 6 active clinical trials with 6,698 planned participants, across 5 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early.

Trial track record · since 2021

6Active trials6,698 planned participants
10Completed0 with results posted
0Stopped early0% of finished trials

Pipeline · 6 active trials

StageTrialStatus

Questions about bioLytical Laboratories

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-04.

Approve Suite is not affiliated with bioLytical Laboratories.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.